World-class process Research and Development are crucial in developing robust and dependable drug development and commercial processes at Agno Pharma. We support process design, route scouting, safety evaluation, process optimization, and continuous process improvement, striving for safer, more robust, cost-effective, and environmentally friendly processes. Our advancements in flow chemistry and biotransformation exemplify these efforts and cater to projects at various stages of development. Our team of 70 process-development chemists in Suzhou excels in creating commercial processes tailored for Agno Pharma’s wholly owned cGMP manufacturing facility in Lianyungang, Jiangsu Province. Typically, our Suzhou R&D staff travel to our production facility to ensure seamless chemistry transfer.

Our expertise can expedite your project from laboratory experimentation to clinical trials while maximizing value through a phase-appropriate approach. Agno Pharma’s comprehensive process development strategy aims to mitigate risks by ensuring safety and reproducibility from laboratory experiments to full-scale production. Leveraging our extensive experience, we naturally recommend starting materials, intermediate specifications, impurity profiling and isolation, proven acceptable range (PAR) parameters, and identification of critical process parameters (CPP). Advanced analytical methods underpin all our process activities, validating every decision.